Atypical CLN2 with later onset and prolonged course: A neuropathologic study showing different sensitivity of neuronal subpopulations to TPP1 deficiency

Acta Neuropathologica

Volumn 116, Issue 1, 2008, Pages 119-124

  Elleder, Milan ^a   Dvořáková, Lenka ^a   Stolnaja, Larisa ^a   Vlášková, Hana ^a   Hålková, Helena ^a   Druga, Rastislav ^b   Poupětová, Helena ^a   Košťálová, Eva ^a   Mikuláštík, Josef ^c  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c REGIONAL HOSPITAL LIBEREC   (Czech Republic)

Author keywords

Atypical course; CLN 2; Neuropathology; Storage pattern

Indexed keywords

GENE PRODUCT; PEPTIDASE; PROTEIN CLN2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE SUBUNIT C; TRIPEPTIDYL PEPTIDASE I;

ADOLESCENT; ARTICLE; AUTOPSY; BLINDNESS; BRAIN ATROPHY; BRAIN BIOPSY; CASE REPORT; CELL LOSS; CELL POPULATION; CEREBELLUM DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DNA DETERMINATION; ELECTROENCEPHALOGRAPHY; EXON; EXTRAPYRAMIDAL SYNDROME; FATALITY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENTAL DETERIORATION; MOTOR DYSFUNCTION; MUTATIONAL ANALYSIS; NERVE CELL; NEURONAL CEROID LIPOFUSCINOSIS; NUCLEOTIDE SEQUENCE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADOLESCENT; AGE OF ONSET; BRAIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENDOPEPTIDASES; HUMANS; INCLUSION BODIES; MALE; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NEURONAL CEROID-LIPOFUSCINOSES; NEURONS;

EID: 47749156846     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-008-0349-3     Document Type: Article

References (28)

1. Bednar B, Dittrich J, Jirasek A, Smid F, Vacek R (1967) Juvenile familiar amaurotic idiocy and myoclonic forms of cerebral lipidoses (in Czech). Cs patol 3:141-149
2. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162:156-159
3. de Baecque CM, Pollack MA, Suzuki K (1976) Late infantile neuronal storage disease with curvilinear bodies. Arch Pathol Lab Med 100:139-144
4. Elleder M (1978) A histochemical and ultrastructural study of stored material in neuronal ceroid lipofuscinosis. Virchows Arch B Cell Pathol 28:167-178
5. Elleder M, Kraus J, Nevsimalova S, Sixtova K, Zeman J (1999) NCL in Different European Countries. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (batten disease). IOS Press, Amsterdam, pp 129
6. Elleder M, Lake BD, Goebel HH, Rapola J, Haltia M, Carpenter S (1999) Definitions of the Ultrastructural Patterns found in NCL. In: Goebel HH, Mole SE, Lake BD (eds) The neuronal ceroid lipofuscinoses (batten disease). IOS Press, Amsterdam, pp 5-15
7. Elleder M, Sokolova J, Hrebicek M (1997) Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93:379-390
8. Elleder M, Tyynela J (1998) Incidence of neuronal perikaryal spheroids in neuronal ceroid lipofuscinoses (batten disease). Clin Neuropathol 17:184-189
9. Ezaki J, Kominami E (2004) The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol 14:77-85
10. Haberland C, Brunngraber EG, Witting LA, Hof H (1972) Late infantile amaurotic idiocy (LIAI). Anatomochemical report of a case. Neurology 22:305-311
11. Hartikainen JM, Ju W, Wisniewski KE, Moroziewicz DN, Kaczmarski AL, McLendon L, Zhong D, Suarez CT, Brown WT, Zhong N (1999) Late infantile neuronal ceroid lipofuscinosis is due to splicing mutations in the CLN2 gene. Mol Genet Metab 67:162-168
12. Ju W, Zhong R, Moore S, Moroziewicz D, Currie JR, Parfrey P, Brown WT, Zhong N (2002) Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles. J Med Genet 39:822-825
13. Kyttala A, Lahtinen U, Braulke T, Hofmann SL (2006) Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim Biophys Acta 1762:920-933
14. Lin L, Lobel P (2001) Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations. Hum Mutat 18:165
15. Mole SE (2004) The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 14:70-76
16. Ramadan H, Al-Din AS, Ismail A, Balen F, Varma A, Twomey A, Watts R, Jackson M, Anderson G, Green E, Mole SE (2007) Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1. Neurology 68:387-388
17. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynela J (2006) Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129:1438-1445
18. Sleat DE, Donnelly RJ, Lackland H, Liu CG, Sohar I, Pullarkat RK, Lobel P (1997) Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277:1802-1805
19. Steinfeld R, Heim P, von Gregory H, Meyer K, Ullrich K, Goebel HH, Kohlschutter A (2002) Late infantile neuronal ceroid lipofuscinosis: quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112:347-354
20. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J (2006) Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 78:988-998
21. Tyynela J, Cooper JD, Khan MN, Shemilts SJ, Haltia M (2004) Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: Distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathol 14:349-357
22. van Diggelen OP, Thobois S, Tilikete C, Zabot MT, Keulemans JL, van Bunderen PA, Taschner PE, Losekoot M, Voznyi YV (2001) Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol 50:269-272
23. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376:584-587
24. Williams RE (1999) CLN2, Classic Late Infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds) The Neuronal Ceroid Lipofuscinoses (Batten Disease). IOS Press, Amsterdam, pp 37-40
25. Wisniewski KE, Kaczmarski A, Kida E, Connell F, Kaczmarski W, Michalewski MP, Moroziewicz DN, Zhong N (1999) Reevaluation of neuronal ceroid lipofuscinoses: Atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248-252
26. Wisniewski KE, Kida E, Golabek AA, Kaczmarski W, Connel F, Zhong N (2001) Neuronal Ceroid Lipofuscinoses: Classification and Diagnosis.In Advances in Genetics. Academic Press, New York, pp 1-30
27. Wlodawer A, Durell SR, Li M, Oyama H, Oda K, Dunn BM (2003) A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct Biol 3:8
28. Young EP, Worthington VC, Jackson M, Winchester BG (2001) Pre-and postnatal diagnosis of patients with CLN1 and CLN2 by assay of palmitoyl-protein thioesterase and tripeptidyl-peptidase I activities. Eur J Paediatr Neurol 5(Suppl A):193-196